Flerlage JE, Kelly KM, Beishuizen A, et al. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer 2017;64:e26421.

• Crossref
• PubMed
Flerlage JE, Kelly KM, Beishuizen A, Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer 2017;64:e26421.10.1002/pbc.26421)| false
• Search Google Scholar
• Export Citation

Henderson TO, Parsons SK, Wroblewski KE, et al. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: an adult intergroup (E2496) and Children’s Oncology Group (COG AHOD0031) comparative analysis. Cancer 2018;124:136–144.

• Crossref
• PubMed
Henderson TO, Parsons SK, Wroblewski KE, Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: an adult intergroup (E2496) and Children’s Oncology Group (COG AHOD0031) comparative analysis. Cancer 2018;124:136–144.10.1002/cncr.30979)| false
• Search Google Scholar
• Export Citation

Foltz LM, Song KW, Connors JM. Hodgkin’s lymphoma in adolescents. J Clin Oncol 2006;24:2520–2526.

• Crossref
• PubMed
Foltz LM, Song KW, Connors JM. Hodgkin’s lymphoma in adolescents. J Clin Oncol 2006;24:2520–2526.1673570410.1200/JCO.2005.04.5823)| false
• Search Google Scholar
• Export Citation

Giulino-Roth L, Pei Q, Buxton A, et al. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood 2021;137:1449–1456.

• Crossref
• PubMed
Giulino-Roth L, Pei Q, Buxton A, Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood 2021;137:1449–1456.3351241210.1182/blood.2020007225)| false
• Search Google Scholar
• Export Citation

Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 1998;339:1506–1514.

• Crossref
• PubMed
Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 1998;339:1506–1514.981944910.1056/NEJM199811193392104)| false
• Search Google Scholar
• Export Citation

Schwartz CL, Chen L, McCarten K, et al. Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2017;64:e26278.

• Crossref
• PubMed
Schwartz CL, Chen L, McCarten K, Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2017;64:e26278.10.1002/pbc.26278)| false
• Search Google Scholar
• Export Citation

Mottok A, Johnston RL, Chun Chan F, et al. Prediction of primary treatment outcome using gene expression profiling of pre-treatment biopsies obtained from childhood and adolescent Hodgkin lymphoma patients. Blood 2015;126:175.

• Crossref
• PubMed
Mottok A, Johnston RL, Chun Chan F, Prediction of primary treatment outcome using gene expression profiling of pre-treatment biopsies obtained from childhood and adolescent Hodgkin lymphoma patients. Blood 2015;126:175.10.1182/blood.V126.23.175.175)| false
• Search Google Scholar
• Export Citation

Johnson P, Federico M, Kirkwood A, et al. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. N Engl J Med 2016;374:2419–2429.

• Crossref
• PubMed
Johnson P, Federico M, Kirkwood A, Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. N Engl J Med 2016;374:2419–2429.10.1056/NEJMoa151009327332902)| false
• Search Google Scholar
• Export Citation

Bhakta N, Liu Q, Yeo F, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin’s lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 2016;17:1325–1334.

• Crossref
• PubMed
Bhakta N, Liu Q, Yeo F, Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin’s lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 2016;17:1325–1334.10.1016/S1470-2045(16)30215-7)| false
• Search Google Scholar
• Export Citation

Oeffinger KC, Stratton KL, Hudson MM, et al. Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study [published online February 25, 2021]. J Clin Oncol, doi: https://doi.org/10.1200/JCO.20.01186

• PubMed
Oeffinger KC, Stratton KL, Hudson MM, Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study [published online February 25, 2021]. J Clin Oncol, doi: https://doi.org/10.1200/JCO.20.0118633630659)| false
• Search Google Scholar
• Export Citation

Parsons SK, Kelly MJ, Cohen JT, et al. Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol 2018;182:212–221.

• Crossref
• PubMed
Parsons SK, Kelly MJ, Cohen JT, Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol 2018;182:212–221.10.1111/bjh.1525529707774)| false
• Search Google Scholar
• Export Citation

Rodday AM, Parsons SK, Scharman C, et al. Prognostication for advanced stage Hodgkin lymphoma (HL) in the modern era: a project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium. Blood 2020;136(Suppl 1):16–18.

• Crossref
• PubMed
Rodday AM, Parsons SK, Scharman C, Prognostication for advanced stage Hodgkin lymphoma (HL) in the modern era: a project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium. Blood 2020;136(Suppl 1):16–18.10.1182/blood-2020-135935)| false
• Search Google Scholar
• Export Citation